Graves' ophthalmopathy (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Graves' ophthalmopathy" in English language version.

refsWebsite

Global rank English rank

29nih.gov

4^th place

21doi.org

2^nd place

2fda.gov

447^th place

338^th place

2web.archive.org

1^st place

2semanticscholar.org

11^th place

8^th place

1eophtha.com

low place

1medscape.com

719^th place

636^th place

1snof.org

low place

1uptodate.com

3,771^st place

2,605^th place

1whonamedit.com

2,888^th place

2,730^th place

doi.org

Bahn RS (February 2010). "Graves' ophthalmopathy". The New England Journal of Medicine. 362 (8): 726–738. doi:10.1056/NEJMra0905750. PMC 3902010. PMID 20181974.
Wiersinga WM, Bartalena L (October 2002). "Epidemiology and prevention of Graves' ophthalmopathy". Thyroid. 12 (10): 855–860. doi:10.1089/105072502761016476. PMID 12487767.
Kan E, Kan EK, Ecemis G, Colak R (2014-08-18). "Presence of thyroid-associated ophthalmopathy in Hashimoto's thyroiditis". International Journal of Ophthalmology. 7 (4): 644–647. doi:10.3980/j.issn.2222-3959.2014.04.10. PMC 4137199. PMID 25161935.
Solomon DH, Chopra IJ, Chopra U, Smith FJ (January 1977). "Identification of subgroups of euthyroid graves's ophthalmopathy". The New England Journal of Medicine. 296 (4): 181–186. doi:10.1056/nejm197701272960401. PMID 576175.
Feldon SE, Muramatsu S, Weiner JM (October 1984). "Clinical classification of Graves' ophthalmopathy. Identification of risk factors for optic neuropathy". Archives of Ophthalmology. 102 (10): 1469–1472. doi:10.1001/archopht.1984.01040031189015. PMID 6548373.
Ohtsuka K (October 1997). "Intraocular pressure and proptosis in 95 patients with Graves ophthalmopathy". American Journal of Ophthalmology. 124 (4): 570–572. doi:10.1016/s0002-9394(14)70883-9. PMID 9323958.
Tan NY, Leong YY, Lang SS, Htoon ZM, Young SM, Sundar G (May 2017). "Radiologic Parameters of Orbital Bone Remodeling in Thyroid Eye Disease". Investigative Ophthalmology & Visual Science. 58 (5): 2527–2533. doi:10.1167/iovs.16-21035. PMID 28492870.
Cawood T, Moriarty P, O'Shea D (August 2004). "Recent developments in thyroid eye disease". BMJ. 329 (7462): 385–390. doi:10.1136/bmj.329.7462.385. PMC 509348. PMID 15310608.
De Bellis A, Conzo G, Cennamo G, Pane E, Bellastella G, Colella C, et al. (April 2012). "Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study". Endocrine. 41 (2): 320–326. doi:10.1007/s12020-011-9559-x. PMID 22169963. S2CID 8197441.
Shah K, Charitou M (2022-07-01). "A Novel Case of Hyperglycemic Hyperosmolar State After the Use of Teprotumumab in a Patient With Thyroid Eye Disease". AACE Clinical Case Reports. 8 (4): 148–149. doi:10.1016/j.aace.2022.01.004. PMC 9363510. PMID 35959086.
Ruchała M, Sawicka-Gutaj N (July 2016). "Advances in the pharmacological treatment of Graves' orbitopathy". Expert Review of Clinical Pharmacology. 9 (7): 981–989. doi:10.1586/17512433.2016.1165606. PMID 26966785. S2CID 9780703.
Hamed Azzam S, Kang S, Salvi M, Ezra DG, et al. (Cochrane Eyes and Vision Group) (November 2018). "Tocilizumab for thyroid eye disease". The Cochrane Database of Systematic Reviews. 2018 (11): CD012984. doi:10.1002/14651858.CD012984.pub2. PMC 6517231. PMID 30480323.
Takamura Y, Nakano K, Uruno T, Ito Y, Miya A, Kobayashi K, et al. (October 2003). "Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy". Endocrine Journal. 50 (5): 595–601. doi:10.1507/endocrj.50.595. PMID 14614216.
Bhargav PR, Sabaretnam M, Kumar SC, Zwalitha S, Devi NV (December 2017). "Regression of Ophthalmopathic Exophthalmos in Graves' Disease After Total Thyroidectomy: a Prospective Study of a Surgical Series". The Indian Journal of Surgery. 79 (6): 521–526. doi:10.1007/s12262-016-1516-8. PMC 5711711. PMID 29217903.
Nart A, Uslu A, Aykas A, Yuzbasioglu F, Dogan M, Demirtas O, Simsek C (July 2008). "Total thyroidectomy for the treatment of recurrent graves' disease with ophthalmopathy". Asian Journal of Surgery. 31 (3): 115–118. doi:10.1016/S1015-9584(08)60070-6. PMID 18658008.
Lowery AJ, Kerin MJ (October 2009). "Graves' ophthalmopathy: the case for thyroid surgery". The Surgeon. 7 (5): 290–296. doi:10.1016/s1479-666x(09)80007-3. PMID 19848063.
Liu ZW, Masterson L, Fish B, Jani P, Chatterjee K (November 2015). "Thyroid surgery for Graves' disease and Graves' ophthalmopathy". The Cochrane Database of Systematic Reviews (11): CD010576. doi:10.1002/14651858.CD010576.pub2. PMC 11189635. PMID 26606533.
Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O (January 2008). "TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study". European Journal of Endocrinology. 158 (1): 69–75. doi:10.1530/EJE-07-0450. PMID 18166819.
Bartalena L, Macchia PE, Marcocci C, Salvi M, Vermiglio F (April 2015). "Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement". Journal of Endocrinological Investigation. 38 (4): 481–487. doi:10.1007/s40618-015-0257-z. PMC 4374116. PMID 25722226.
Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA (March 1996). "Clinical features of Graves' ophthalmopathy in an incidence cohort". American Journal of Ophthalmology. 121 (3): 284–290. doi:10.1016/s0002-9394(14)70276-4. PMID 8597271.
Bartalena L, Marcocci C, Pinchera A (April 2002). "Graves' ophthalmopathy: a preventable disease?". European Journal of Endocrinology. 146 (4): 457–461. doi:10.1530/eje.0.1460457. PMID 11916611.

eophtha.com

Rao R (2013). "Thyroid Eye diseases". Online Resources of Ophthalmology. Archived from the original on 2014-04-17. Retrieved 2013-09-04.

fda.gov

Office of the Commissioner (2020-03-24). "FDA approves first treatment for thyroid eye disease". FDA. Retrieved 2021-02-06.
"FDA approves first treatment for thyroid eye disease". FDA. 21 January 2020. Retrieved 27 January 2020.

medscape.com

Kuehn BM (15 December 2014). "Surgery, Statins Linked to Lower Graves' Complication Risk". Medscape Medical News.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bahn RS (February 2010). "Graves' ophthalmopathy". The New England Journal of Medicine. 362 (8): 726–738. doi:10.1056/NEJMra0905750. PMC 3902010. PMID 20181974.
Wiersinga WM, Bartalena L (October 2002). "Epidemiology and prevention of Graves' ophthalmopathy". Thyroid. 12 (10): 855–860. doi:10.1089/105072502761016476. PMID 12487767.
Kan E, Kan EK, Ecemis G, Colak R (2014-08-18). "Presence of thyroid-associated ophthalmopathy in Hashimoto's thyroiditis". International Journal of Ophthalmology. 7 (4): 644–647. doi:10.3980/j.issn.2222-3959.2014.04.10. PMC 4137199. PMID 25161935.
Solomon DH, Chopra IJ, Chopra U, Smith FJ (January 1977). "Identification of subgroups of euthyroid graves's ophthalmopathy". The New England Journal of Medicine. 296 (4): 181–186. doi:10.1056/nejm197701272960401. PMID 576175.
Feldon SE, Muramatsu S, Weiner JM (October 1984). "Clinical classification of Graves' ophthalmopathy. Identification of risk factors for optic neuropathy". Archives of Ophthalmology. 102 (10): 1469–1472. doi:10.1001/archopht.1984.01040031189015. PMID 6548373.
Ohtsuka K (October 1997). "Intraocular pressure and proptosis in 95 patients with Graves ophthalmopathy". American Journal of Ophthalmology. 124 (4): 570–572. doi:10.1016/s0002-9394(14)70883-9. PMID 9323958.
Tan NY, Leong YY, Lang SS, Htoon ZM, Young SM, Sundar G (May 2017). "Radiologic Parameters of Orbital Bone Remodeling in Thyroid Eye Disease". Investigative Ophthalmology & Visual Science. 58 (5): 2527–2533. doi:10.1167/iovs.16-21035. PMID 28492870.
Cawood T, Moriarty P, O'Shea D (August 2004). "Recent developments in thyroid eye disease". BMJ. 329 (7462): 385–390. doi:10.1136/bmj.329.7462.385. PMC 509348. PMID 15310608.
De Bellis A, Conzo G, Cennamo G, Pane E, Bellastella G, Colella C, et al. (April 2012). "Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study". Endocrine. 41 (2): 320–326. doi:10.1007/s12020-011-9559-x. PMID 22169963. S2CID 8197441.
Shah K, Charitou M (2022-07-01). "A Novel Case of Hyperglycemic Hyperosmolar State After the Use of Teprotumumab in a Patient With Thyroid Eye Disease". AACE Clinical Case Reports. 8 (4): 148–149. doi:10.1016/j.aace.2022.01.004. PMC 9363510. PMID 35959086.
Ruchała M, Sawicka-Gutaj N (July 2016). "Advances in the pharmacological treatment of Graves' orbitopathy". Expert Review of Clinical Pharmacology. 9 (7): 981–989. doi:10.1586/17512433.2016.1165606. PMID 26966785. S2CID 9780703.
Hamed Azzam S, Kang S, Salvi M, Ezra DG, et al. (Cochrane Eyes and Vision Group) (November 2018). "Tocilizumab for thyroid eye disease". The Cochrane Database of Systematic Reviews. 2018 (11): CD012984. doi:10.1002/14651858.CD012984.pub2. PMC 6517231. PMID 30480323.
Takamura Y, Nakano K, Uruno T, Ito Y, Miya A, Kobayashi K, et al. (October 2003). "Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy". Endocrine Journal. 50 (5): 595–601. doi:10.1507/endocrj.50.595. PMID 14614216.
Bhargav PR, Sabaretnam M, Kumar SC, Zwalitha S, Devi NV (December 2017). "Regression of Ophthalmopathic Exophthalmos in Graves' Disease After Total Thyroidectomy: a Prospective Study of a Surgical Series". The Indian Journal of Surgery. 79 (6): 521–526. doi:10.1007/s12262-016-1516-8. PMC 5711711. PMID 29217903.
Nart A, Uslu A, Aykas A, Yuzbasioglu F, Dogan M, Demirtas O, Simsek C (July 2008). "Total thyroidectomy for the treatment of recurrent graves' disease with ophthalmopathy". Asian Journal of Surgery. 31 (3): 115–118. doi:10.1016/S1015-9584(08)60070-6. PMID 18658008.
Lowery AJ, Kerin MJ (October 2009). "Graves' ophthalmopathy: the case for thyroid surgery". The Surgeon. 7 (5): 290–296. doi:10.1016/s1479-666x(09)80007-3. PMID 19848063.
Liu ZW, Masterson L, Fish B, Jani P, Chatterjee K (November 2015). "Thyroid surgery for Graves' disease and Graves' ophthalmopathy". The Cochrane Database of Systematic Reviews (11): CD010576. doi:10.1002/14651858.CD010576.pub2. PMC 11189635. PMID 26606533.
Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O (January 2008). "TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study". European Journal of Endocrinology. 158 (1): 69–75. doi:10.1530/EJE-07-0450. PMID 18166819.
Bartalena L, Macchia PE, Marcocci C, Salvi M, Vermiglio F (April 2015). "Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement". Journal of Endocrinological Investigation. 38 (4): 481–487. doi:10.1007/s40618-015-0257-z. PMC 4374116. PMID 25722226.
Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA (March 1996). "Clinical features of Graves' ophthalmopathy in an incidence cohort". American Journal of Ophthalmology. 121 (3): 284–290. doi:10.1016/s0002-9394(14)70276-4. PMID 8597271.
Bartalena L, Marcocci C, Pinchera A (April 2002). "Graves' ophthalmopathy: a preventable disease?". European Journal of Endocrinology. 146 (4): 457–461. doi:10.1530/eje.0.1460457. PMID 11916611.

ncbi.nlm.nih.gov

Bahn RS (February 2010). "Graves' ophthalmopathy". The New England Journal of Medicine. 362 (8): 726–738. doi:10.1056/NEJMra0905750. PMC 3902010. PMID 20181974.
Kan E, Kan EK, Ecemis G, Colak R (2014-08-18). "Presence of thyroid-associated ophthalmopathy in Hashimoto's thyroiditis". International Journal of Ophthalmology. 7 (4): 644–647. doi:10.3980/j.issn.2222-3959.2014.04.10. PMC 4137199. PMID 25161935.
Cawood T, Moriarty P, O'Shea D (August 2004). "Recent developments in thyroid eye disease". BMJ. 329 (7462): 385–390. doi:10.1136/bmj.329.7462.385. PMC 509348. PMID 15310608.
Shah K, Charitou M (2022-07-01). "A Novel Case of Hyperglycemic Hyperosmolar State After the Use of Teprotumumab in a Patient With Thyroid Eye Disease". AACE Clinical Case Reports. 8 (4): 148–149. doi:10.1016/j.aace.2022.01.004. PMC 9363510. PMID 35959086.
Hamed Azzam S, Kang S, Salvi M, Ezra DG, et al. (Cochrane Eyes and Vision Group) (November 2018). "Tocilizumab for thyroid eye disease". The Cochrane Database of Systematic Reviews. 2018 (11): CD012984. doi:10.1002/14651858.CD012984.pub2. PMC 6517231. PMID 30480323.
Bhargav PR, Sabaretnam M, Kumar SC, Zwalitha S, Devi NV (December 2017). "Regression of Ophthalmopathic Exophthalmos in Graves' Disease After Total Thyroidectomy: a Prospective Study of a Surgical Series". The Indian Journal of Surgery. 79 (6): 521–526. doi:10.1007/s12262-016-1516-8. PMC 5711711. PMID 29217903.
Liu ZW, Masterson L, Fish B, Jani P, Chatterjee K (November 2015). "Thyroid surgery for Graves' disease and Graves' ophthalmopathy". The Cochrane Database of Systematic Reviews (11): CD010576. doi:10.1002/14651858.CD010576.pub2. PMC 11189635. PMID 26606533.
Bartalena L, Macchia PE, Marcocci C, Salvi M, Vermiglio F (April 2015). "Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement". Journal of Endocrinological Investigation. 38 (4): 481–487. doi:10.1007/s40618-015-0257-z. PMC 4374116. PMID 25722226.

semanticscholar.org

api.semanticscholar.org

De Bellis A, Conzo G, Cennamo G, Pane E, Bellastella G, Colella C, et al. (April 2012). "Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study". Endocrine. 41 (2): 320–326. doi:10.1007/s12020-011-9559-x. PMID 22169963. S2CID 8197441.
Ruchała M, Sawicka-Gutaj N (July 2016). "Advances in the pharmacological treatment of Graves' orbitopathy". Expert Review of Clinical Pharmacology. 9 (7): 981–989. doi:10.1586/17512433.2016.1165606. PMID 26966785. S2CID 9780703.

snof.org

Muratet JM. "Eyelid retraction". Ophthalmic Plastic Surgery. Le Syndicat National des Ophtalmologistes de France. Archived from the original on June 9, 2007. Retrieved 2007-07-12.

uptodate.com

Davies TF, Burch HB (September 2009). Ross DS, Martin KA (eds.). "Pathogenesis and clinical features of Graves' ophthalmopathy (orbitopathy)". UpToDate.

web.archive.org

Rao R (2013). "Thyroid Eye diseases". Online Resources of Ophthalmology. Archived from the original on 2014-04-17. Retrieved 2013-09-04.
Muratet JM. "Eyelid retraction". Ophthalmic Plastic Surgery. Le Syndicat National des Ophtalmologistes de France. Archived from the original on June 9, 2007. Retrieved 2007-07-12.

whonamedit.com

Robert James Graves at Who Named It?